Human herpesvirus 6 lymphadenitis in drug rash with eosinophilia and systemic symptoms syndrome: a lymphoma mimic

Histopathology

Volumn 70, Issue 7, 2017, Pages 1166-1170

  Johnson, Steven ^a   Mathews, Stephanie ^a   Hudnall, S David ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug rash with eosinophilia and systemic symptoms; human herpesvirus 6; lymphadenopathy; T cell lymphoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CD3 ANTIGEN; CD7 ANTIGEN; IMMUNOGLOBULIN M; PREDNISONE; SALAZOSULFAPYRIDINE; VANCOMYCIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CERVICAL LYMPH NODE; DRESS SYNDROME; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEUKOCYTOSIS; LYMPH NODE BIOPSY; LYMPHADENITIS; LYMPHADENOPATHY; LYMPHOMA; MEDICAL HISTORY; PRIORITY JOURNAL; PUNCH BIOPSY; RHEUMATOID ARTHRITIS; VIRUS REACTIVATION; ADULT; CASE REPORT; COMPLICATION; DIFFERENTIAL DIAGNOSIS; EXANTHEMA SUBITUM; FEMALE; T CELL LYMPHOMA; VIROLOGY;

ADULT; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY SYNDROME; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; LYMPHADENITIS; LYMPHOMA, T-CELL; ROSEOLOVIRUS INFECTIONS;

EID: 85015031619     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.13157     Document Type: Article

References (22)

1. Cacoub P, Musette P, Descamps V et al. The DRESS syndrome: a literature review. Am. J. Med. 2011; 124; 588–597.
2. Yamanishi K, Okuno T, Shiraki K et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1; 1065–1067.
3. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol. Int. 2006; 55; 1–8.
4. Eshki M, Allanore L, Musette P et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch. Dermatol. 2009; 145; 67–72.
5. Tohyama M, Hashimoto K, Yasukawa M et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br. J. Dermatol. 2007; 157; 934–940.
6. Ortonne N, Valeyrie-Allanore L, Bastuji-Garin S et al. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. Br. J. Dermatol. 2015; 173; 50.
7. Chen Y, Chiang H, Cho Y et al. Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions – a prospective comparative study. Allergy 2015; 70; 568–575.
8. Blumenthal K, Patil S, Long A. The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Allergy Asthma Proc. 2012; 33; 165–171.
9. Ablashi D, Agut H, Alvarez-Lafuente R et al. Classification of HHV-6A and HHV-6B as distinct viruses. Arch. Virol. 2014; 159; 863–870.
10. Dewhurst S, McIntyre K, Schnabel K et al. Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J. Clin. Microbiol. 1993; 31; 416–418.
11. Yamamoto T, Mukai T, Kondo K et al. Variation of DNA sequence in immediate-early gene of human herpesvirus 6 and variant identification by PCR. J. Clin. Microbiol. 1994; 32; 473–476.
12. Shiohara T, Iijima M, Ikezawa Z et al. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br. J. Dermatol. 2007; 156; 1083–1084.
13. Ushigome Y, Kano Y, Hirahara K et al. Human herpesvirus 6 reactivation in drug-induced hypersensitivity syndrome and DRESS validation score. Am. J. Med. 2012; 125; e9–e10.
14. Fiszenson-Albala F, Auzerie V, Mahe E et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br. J. Dermatol. 2003; 149; 1018–1022.
15. Weisberger J, Cornfield D, Gorczyca W et al. Down-regulation of pan-T-cell antigens, particularly CD7, in acute infectious mononucleosis. Am. J. Clin. Pathol. 2003; 120; 49–55.
16. Flammiger A, Bacher U, Christopeit M et al. Multiparameter flow cytometry in the differential diagnosis of aberrant T-cell clones of unclear significance. Leuk. Lymph. 2015; 56; 639–644.
17. Maric I, Bryant R, Abu-Asab M et al. Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults. Mod. Pathol. 2004; 17; 1427–1433.
18. Bai Y, Wang Z, Sun K et al. HHV-6-associated acute lymphadenitis in immunocompetent patients: a case report and review of literature. Int. J. Clin. Exp. Pathol. 2014; 15; 3413–3417.
19. Saraya T, Mikoshiba M, Kamiyama H et al. Evidence for reactivation of human herpesvirus 6 in generalized lymphadenopathy in a patient with drug-induced hypersensitivity syndrome. J. Clin. Microbiol. 2013; 51; 1979–1982.
20. Mine S, Suzuki K, Sato Y et al. Evidence for human herpesvirus-6B infection of regulatory T-cells in acute systemic lymphadenitis in an immunocompetent adult with the drug reaction with eosinophilia and systemic symptoms syndrome: a case report. J. Clin. Virol. 2014; 61; 448–452.
21. + T cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms. Clin. Exp. Dermatol. 2014; 39; 284–291.
22. Hanafusa T, Azukizawa H, Matsumura S et al. The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity. J. Dermatol. Sci. 2012; 65; 213–219.